Trump's State of the Union address highlighted his year-one milestones, including tax reform, expanded defense budget, and stock market performance. Ben Phillips, Chief Investment Officer at EventShares, was with us to discuss how the speech could impact markets.
Stocks rebounded from a 2-day sell-off the day after President Trump delivered his speech. Phillips says his tone was more presidential, and the markets were responding positively. Phillips highlighted tax reform as a catalyst for more gains for the year ahead, saying it is a major boost to many corporations.
President Trump called on Congress for a bill that raises $1.5 billion on infrastructure. EventShares created the first-ever policy driven portfolios. Phillips gave insight into which stocks could benefit based off policies from the GOP and Democrats. Phillips also said he was concerned stocks could be hitting a top.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
